About US
Contact us
-
SFDA issues National Standard for Basic Instruments and Equipments of Medical Device Testing Institutions (2011-2015)To enhance the testing capacity building of medical device testing institutions, standardize the instruments and equipments of medical device testing institutions and improve the supervision of medial2012/3/5
-
GSK, Daiichi team to develop, launch vaccines in JapanJust last week, GlaxoSmithKline ($GSK)CEO Andrew Witty (photo) slighted European markets by touting Japan as a superior place to sell drugsthese days. Japan's moves to speed new drugs to market and it2012/3/2
-
SFDA issues the 2011-2015 Work Plan for Electronic Supervision of DrugsThe State Food and Drug Administration (SFDA) recently issued the 2011-2015 Work Plan for Electronic Supervision of Drugs. The plan defines the guidelines, objectives, main tasks, work arrangements an2012/3/2
-
FDA cites contaminated vials, insects in APP warning letterThe FDA has posted its warning letter about APP Pharmaceuticals' New York plant, and the citations aren't pretty: Agency inspectors cited insects found in the drug production area, not to mention in s2012/3/1
-
Pfizer puts Emergen-C into its consumer med cabinetPfizer ($PFE) is snapping up the company that makes Emergen-C, those ubiquitous vitamin C packets that sell for some $10 a box. The world's biggest drugmaker will add California-based Alacer to its co2012/3/1
-
In drugs vs. stents debate, another point for medsMore ammo for drugmakers in the ongoing battle of stents vs. pills. A U.S. study found drug therapy works just as well for stable patients with narrowed heart arteries, without the risks and costs of2012/2/29
-
SFDA Commissioner Yin Li meets Director of Health Bureau of Macao SAR and signs cooperation agreementOn February 23, 2012, Yin Li, Commissioner of the State Food and Drug Administration (SFDA), met with Dr. Lei Chin Ion, Director of the Health Bureau of Government of Macao Special Administrative Regi2012/2/29
-
Lilly adds to Irish ops with $440M plantIrish officials may be worried about drug exports bottoming out with the patent cliff--and with good reason. But Eli Lilly ($LLY) has given the pharma industry there a new boost: The U.S.-based compan2012/2/28
-
GSK chief: Officials delay new meds to save moneyGlaxoSmithKline ($GSK)chief Andrew Witty (pictured) is raising a ruckus in Europe, accusing governments of not only cutting prices and drug budgets, but holding off on adopting newmeds to save money.2012/2/28
-
Field narrows in contest for Pfizer's nutrition unitThe contest for Pfizer's nutrition unit is heating up. Mead Johnson, the baby-formula business spun off by Bristol-Myers Squibb ($BMY) in 2009, has teamed up with the French food giant Danone on a bid2012/2/27